Skip to main content
. 2019 Jun 26;11(6):1139–1148. doi: 10.1080/19420862.2019.1629239

Table 2.

Pharmacokinetic parameters of LBL-007 antibody levels in monkeys.

    t1/2
C5min
AUClast
AUC0-∞
V
CL
MRTlast
dose
(mg/kg)
  (h) (µg/mL) (h*µg/mL) (h*µg/mL) (mL/kg) (mL/h/kg) (h)
3 Mean 275.31 73.22 9013.81 11364.48 109.27 0.27 229.32
SD 13.87 17.27 2327.64 2970.21 33.84 0.07 5.17
10 Mean 335.31 194.4 26601.72 34144.9 148.28 0.31 224.5
SD 36.9 53.34 9867.22 12139.57 37.13 0.11 5.52
30 Mean 193.52 616.15 63570.08 69937.95 119.44 0.43 203.43
SD 31.95 122.23 934.48 3042.52 14.57 0.02 2.54

Pharmacokinetic parameters were calculated using a non-compartmental analysis. T1/2, half-life; C5min, concentration of 5 min; AUC, The area under the concentration versus time curve; V, apparent volume of distribution; CL, clearance; MRT, Mean Residence Time.

HHS Vulnerability Disclosure